SEC Filing Summary: Form 6-K
Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV (a foreign private issuer), not Lakefront Biotherapeutics NV as indicated in the request metadata. The filing date is April 27, 2018, with a signature date of May 1, 2018. The document serves to incorporate by reference a press release (Exhibit 99.1) issued on April 27, 2018, into the company's existing Registration Statements on Forms F-3 and S-8.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute a press release and does not contain a financial statement or quantitative data within the provided text.
Material Changes
No material financial changes versus a prior comparable period are detailed in this text. The filing references a press release but does not summarize its specific content or financial impact.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It solely confirms the incorporation of an external press release into the company's registration statements.
Investor Verification Checklist
- Verify the correct registrant name is Galapagos NV, not Lakefront Biotherapeutics NV.
- Locate and review the attached Exhibit 99.1 (Press Release dated April 27, 2018) for the actual material event or announcement.
- Confirm the impact of the press release on the company's Registration Statements (File Nos. 333-211765, 333-204567, 333-208697, 333-211834, 333-215783, and 333-218160).